FDA — authorised 15 November 2018
- Application: ANDA205067
- Marketing authorisation holder: DR REDDYS
- Status: supplemented
FDA authorised propofol injectable emulsion on 15 November 2018
Yes. FDA authorised it on 15 November 2018.
DR REDDYS holds the US marketing authorisation.